Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Parandoosh, Z.
Right arrow Articles by Nova, M. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Parandoosh, Z.
Right arrow Articles by Nova, M. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Synthesis Coupled to Scintillation Proximity Affinity Screening

Zahra Parandoosh

IRORI, 11149 North Torrey Pines Road, La Jolla, CA 92037-1031

Sue K. Knowles

IRORI, 11149 North Torrey Pines Road, La Jolla, CA 92037-1031

Xiao-Yi Xiao

IRORI, 11149 North Torrey Pines Road, La Jolla, CA 92037-1031

Chanfeng Zhao

IRORI, 11149 North Torrey Pines Road, La Jolla, CA 92037-1031

Gary S. David

Impact Enterprises, 9477 Poole St., La Jolla, CA 92037

Michael P. Nova

IRORI, 11149 North Torrey Pines Road, La Jolla, CA 92037-1031

The rapidly changing developments in genomics and combinatorial chemistry, generating new drug targets and large numbers of compounds, are beginning to push the limits of screening efficiently. Thus, there is a need for novel tools and strategies to improve high throughput screening. A novel approach is to couple synthesis and screening on a common platform, rather than to increase the rate at which traditional screening methods can be implemented. We have developed a proprietary grafted polymer with special fluorescence characteristics referred to as Electronically Encoded Fluorescence matriX (EFXTM), which has the sturdiness and required functionality for direct chemical synthesis as well as suitable surface characteristics for measuring interactions in aqueous solution. This matrix is fabricated into a MicroTube reactor, and each tube is associated with an electronically encoded tag. The system follows a homogenous assay protocol and is based on the scintillation proximity principle. Using solid-phase chemistry, a variety of small molecules may be synthesized onto the EFX. A simple binding assay can be conducted by combining a collection of MicroTubes with any radiolabeled acceptor molecule. The MicroTubes that carry active compounds are selected based on the photon mission or fluorescence characteristics. We validated this approach by evaluating the interactions of biotin with radiolabeled streptavidin.

Journal of Biomolecular Screening, Vol. 3, No. 4, 293-298 (1998)
DOI: 10.1177/108705719800300408


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?